Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Clinical Efficacy and Symptom Control Using Electrochemotherapy for the Inoperable Advanced Vulva Carcinoma

NCT03142061 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03142061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03142061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Clinical Efficacy and Symptom Control Using Electrochemotherapy for the Inoperable Advanced Vulva Carcinoma
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2017
Completion date
December 31, 2019
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced inoperable vulva carcinoma